3-D Matrix is a medical device company that offers innovative peptide technology, revolutionising the way healthcare professionals manage oozing bleeding during surgery. Join our community of healthcare professionals: https://www.linkedin.com/groups/12920054/ Headquartered in Tokyo, Japan, 3-D Matrix has expanded across America, Europe, Middle East and Asia. The company collaborates with many researchers, surgeons, healthcare providers and distributors across the world to continually improve on our product. We keep patient outcome at our heart, operating on three main principles: agility, proactiveness and focus. Follow us on Twitter @3dm_emea Sign up to our newsletter for the latest clinical data and product announcements: https://news.3dmatrix.com/newsletter-subscription
| Website | http://www.3dmatrix.com |
| Revenue | $15 million |
| Employees | 51 (36 on RocketReach) |
| Industry | Medical Equipment Manufacturing |
| Keywords | Peptide Technology, Medical Devices, Innovative Healthcare Solutions, Hemostasis, Bleeding Control, Advanced Wound Care, Minimally Invasive Surgery, Surgical Technology, Biomedical Technology, Healthcare Technology, Medical Technology, Peptide Therapeutics, Drug Delivery, Tissue Repair, Wound Healing, Surgical Instruments, Medical Supplies |
| Competitors | Smith+Nephew, Integra LifeSciences, Organogenesis, KCI USA, Kerecis, LIFECELL LIMITED, Acell Inc, MediWound Ltd., Tissue Regenix Group, Systagenix Wound Management (Germany) GmbH pharmazeutische Produkte chemische Produkte +28 more (view full list) |
Looking for a particular 3-D Matrix EMEA employee's phone or email?
The 3-D Matrix EMEA annual revenue was $15 million in 2026.
Coen van Paassen is the Sales Director of 3-D Matrix EMEA.
36 people are employed at 3-D Matrix EMEA.